Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; ALK; anaplastic lymphoma kinase; ATP; adenosine triphosphate; BCR-ABL; Breakpoint cluster region-Abelson; DMEM; Dulbecco Modified Eagle Medium; EGFR; epidermal growth factor receptor; FUCCI; Fluorescence Ubiquitination Cell Cycle Indicator; HER; human e
مقالات ISI گیرنده عامل فاکتور رشد اپیدرمی انسان (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; AJCC; American Joint Committee on Cancer; BNF; British National Formulary; CI; confidence interval; CPRD; Clinical Practice Research Datalink; ER; oestrogen receptor; GP; general practitioner; HR; hazard ratio; HER2; human epidermal growth factor receptor
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; APTMS; 3-aminopropyltriethoxysilane; 8-OHdG; 8-hydroxydeoxyguanosine; BRE; Bio-recognition element; BRCA-1; Breast cancer 1 gene; CNTs; Carbon nanotubes; CLL; Chronic lymphocytic leukemia; EIS; Electrochemical impedance spectroscopy; ELISA; Enzyme linked
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; AIs; aromatase inhibitors; AMPK; Adenosine Monophosphate-Activated Protein Kinase; AR; androgen; ATM; Ataxia Telangiectasia Mutated; ATP; Adenosine Triphosphate; BCSS; breast cancer specific survival; CK-MB; Creatine Kinase-MB; CREB1; cAMP Response Elemen
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; Automation; Eukaryotic cell-free protein synthesis; Integral membrane protein; Non-canonical amino acid; Electrophysiology; Fluorescence modification; Amb210; amber stop codon at position corresponding to amino acid 210 in translated protein; AzF; p-Azido
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; ECG; electrocardiogram; ED; emergency department; EF; ejection faction; ErbB; gene symbol for the epidermal growth factor receptor; ER; estrogen receptor; HER; human epidermal growth factor receptor; PR; progesterone receptor;
Rhizoma Amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K/Akt/mTOR pathway
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; CAM; complementary and alternative medicine; CCL21; chemokine (C-C motif) ligand 21; CCR7; chemokine (C-C motif) receptor 7; CXCR4; C-X-C chemokine receptor type 4; GC-MS; gas chromatography-mass spectrometry; Her2; human epidermal growth factor receptor
Understanding the biology of HER3 receptor as a therapeutic target in human cancer
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; Ab; antibody; ADCC; antibody-dependent cell-mediated cytotoxicity; EGFR; epidermal growth factor receptor; EMT; epithelial-mesenchymal transition; FDA; Food and Drug Administration; HER; Human epidermal growth factor receptor; HRG; heregulin; IGF-1R; insu
Efficient sortase-mediated N-terminal labeling of TEV protease cleaved recombinant proteins
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; Sortase; Post-labeling purification; TEV; LPXTG; Affinity tag; TEV; Tobacco Etch Virus; EGFR; epidermal growth factor receptor; MSP; membrane scaffold protein; HER; Human Epidermal growth factor Receptor; KD; kinase domain; SrtA; Sortase A; ACP; acyl carr
Beclin1 antagonizes LAPTM4B-mediated EGFR overactivation in gastric cancer cells
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; LAPTM4B; lysosome-associated transmembrane protein 4β; EGFR; epidermal growth factor receptor; TAP; tandem affinity purification; TKI; tyrosine kinase inhibitor; HER; human epidermal growth factor receptor; BSA; bovine serum albumin; MCS; multiple clonin
Impact of a planned dose interruption of dacomitinib in the treatment of advanced non-small-cell lung cancer (ARCHER 1042)
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; NSCLC; non-small-cell lung cancer; HER; Human Epidermal Growth Factor Receptor; EGFR; Epidermal Growth Factor Receptor; Dacomitinib; Non-small-cell lung cancer; Dose interruption; Pharmacokinetic; Supportive care;
Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; AE; adverse event; CI; confidence interval; DBS; dried blood spot; DCR; disease control rate; ECOG PS; Eastern Cooperative Oncology Group performance status; EGFR; epidermal growth factor receptor; HER; human epidermal growth factor receptor; HR; hazard r
Exploring the pharmacological mechanism of Yanghe Decoction on HER2-positive breast cancer by a network pharmacology approach
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; ER; estrogen receptor; PGR; progesterone receptor; HER; human epidermal growth factor receptor; CAM; complementary and alternative medicine; TCM; traditional Chinese medicine; YHD; Yanghe Decoction; OB; oral bioavailability; DL; drug-likeness; PPI; protei
Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; Cancer Stem Cell (CSC); Targeted Therapy; Biologic; Anti-Tumor Agent; CSC; cancer stem cell; EAC; esophageal adenocarcinoma; EMT; epithelial to mesenchymal transition; Erb-b2/HER/ERBB; human epidermal growth factor receptor; FACS; fluorescence-activated c
Endocrine therapy for hormone treatment-naïve advanced breast cancer
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; Advanced breast cancer; Metastatic breast cancer; Endocrine therapy; Endocrine therapy-naïve; CBR; clinical benefit rate; CDK; cyclin-dependent kinase; CI; confidence interval; ER; estrogen receptor; HER; human epidermal growth factor receptor; HR; hazar
Truncation, modification, and optimization of MIG6segment 2 peptide to target lung cancer-related EGFR
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; Human epidermal growth factor receptor; MIG6 protein; Peptide; Lung cancer
ALK-FISH borderline cases in non-small cell lung cancer: Implications for diagnostics and clinical decision making
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; ADC; adenocarcinoma; ADSC; adenosquamous carcinoma; ALK; anaplastic lymphoma kinase; BL; borderline; CNG; copy number gain; EMA; European Medicines Agency; FDA; Food and Drug Administration; FISH; fluorescence in-situ hybridization; FS; fused signals; FN;
BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; Breast cancer; Triple negative breast cancer; BRCA1; Genomic instability; Targeted therapy; TN; triple negative; ER; estrogen receptor; PR; progesterone receptor; HER2; human epidermal growth factor receptor; CNA; copy number aberration; HR; hazard ratio;
Phase I study of the HER3-targeted antibody patritumab (U3-1287) combined with erlotinib in Japanese patients with non-small cell lung cancer
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; HER; human epidermal growth factor receptor; NSCLC; non-small cell lung cancer; DLT; dose-limiting toxicity; MTD; maximum tolerated dose; EGFR-TKI; epidermal growth factor receptor-tyrosine kinase inhibitor; RECIST; response evaluation criteria in solid t
A novel impedimetric disposable immunosensor for rapid detection of a potential cancer biomarker
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; Cancer biomarkers; Biosensor; Human epidermal growth factor receptor; Electrochemical impedance spectroscopy; Single frequency impedance
Circulating tumor-cell detection and capture using microfluidic devices
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; BM; Bone marrow; CTC; Circulating tumor cell; DEP; Dielectrophoresis; EGFR; Epithelial growth factor receptor; EpCAM; Epithelial cell adhesion molecule; HeLa; Cervical cancer cell line; HER; Human epidermal growth factor receptor; LNCaP; Androgen-sensitiv
HER2/HER3 regulates extracellular acidification and cell migration through MTK1 (MEKK4)
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; MAPK; mitogen-activated protein kinase; ERK; extracellular signal-regulated kinase; MAP3K4; mitogen-activated protein kinase kinase kinase 4; MEKK4; mitogen-activated, extracellular signal-regulated kinase kinase; MTK1; mitogen activated protein three kin
The predictive value of serum soluble E-cadherin levels in breast cancer patients undergoing preoperative systemic chemotherapy
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; PST; preoperative systemic therapy; TNM-system; tumor-node-metastasis cancer staging system; DFS; disease-free survival; OS; overall survival; pCR; pathologic complete remission; cT; clinically measured tumor size; ADAM; a disintegrin and metalloprote
Prognostic Role of Human Epidermal Growth Factor Receptor in Gastric Cancer: A Systematic Review and Meta-analysis
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; Gastric cancer; Human epidermal growth factor receptor; EGFR; HER2; Meta-analysis
Efficacy of HER2-targeted therapy in metastatic breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; Breast cancer; Human epidermal growth factor receptor; Lapatinib; Targeted therapy; TrastuzumabAMP, adenosine monophosphate; CBR, clinical benefit rate; CI, confidence interval; CR, complete response; EGFR, epidermal growth factor receptor; ER, estrogen r
Advanced HER2-positive gastric cancer: Current and future targeted therapies
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; Gastric cancer; Human epidermal growth factor receptor; Trastuzumab resistance; Multitargeted tyrosine kinase inhibitors; Second line therapies; Targeted therapies
Pilot and feasibility study: comparative proteomic analysis by 2-DE MALDI TOF/TOF MS reveals 14-3-3 proteins as putative biomarkers of response to neoadjuvant chemotherapy in ER-positive breast cancer
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; BCS; breast conserving surgery; CR; chemotherapy resistant; CS; chemotherapy sensitive; DCE-MRI; dynamic contrast enhanced magnetic resonance imaging; DEP; differentially expressed protein; EC; epirubicin with cyclophosphamide; ER; oestrogen receptor; HER
Heat shock proteins in oncology: Diagnostic biomarkers or therapeutic targets?
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; 2 DE; 2D gel electrophoresis; 2DPAGE; 2D polyacrylamide gel electrophoresis; AIF; Apoptosis inducing factor; Apaf-1; Apoptotic protease activating factor 1; APC; Antigen presenting cell; ASK-1; Apoptosis Signal-regulating Kinase 1; Bag; Bcl-2-associated a
The HER3/ErbB3 receptor: A promising target in cancer drug therapy
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; HER; human epidermal growth factor receptor; RTKs; receptor tyrosine kinases; EGFR; epidermal growth factor receptor; IGF-1R; insulin-like growth factor type 1 receptor; IGF; insulin-like growth factor; EGF; epidermal growth factor; TGF-α; transforming
3D-QSAR CoMFA analysis of C5 substituted pyrrolotriazines as HER2 (ErbB2) inhibitors
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; Receptor tyrosine kinase; EGFR; Human epidermal growth factor receptor; CoMFA
Autocrine regulation of human urothelial cell proliferation and migration during regenerative responses in vitro
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; AR; amphiregulin; BTC; betacellulin; BPE; bovine pituitary extract; EGF; epidermal growth factor; EGFR; epidermal growth factor receptor; EPR; epiregulin; ERK; extracellular regulated kinase; HB-EGF; heparin-binding epidermal growth factor; HER; human epi
Function of alternative splicing
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان; CGRP; calcitonin-gene-related peptide; DSCAM; Down syndrome cell adhesion molecule; GDNF; glial cell line-derived neurotrophic factor; GMAP-210; Golgi-microtubule-associated-protein of 210 kDa; GnRH; gonadotrophin releasing hormone; HER2; human epidermal